Moneycontrol
HomeNewsBusinessMarketsDAILY VOICE | Rise in US bond yields beyond 2% could force EMs to raise interest rates: Divam Sharma of Green Portfolio
Trending Topics

DAILY VOICE | Rise in US bond yields beyond 2% could force EMs to raise interest rates: Divam Sharma of Green Portfolio

Selected mid and small-cap counters have room to grow disproportionately. We keep looking for companies with lesser debt and growth plans, says Sharma.

April 05, 2021 / 08:19 IST
Story continues below Advertisement

Divam Sharma, co-founder of Green Portfolio, feels if the US 10-year bond yields increase beyond 2%, emerging markets like India will have to consider increasing their interest rates, which can have an impact on the current bull run in equity markets.

Story continues below Advertisement

Sharma is a Member of The Institute of Chartered Accountants of India and has over 13 years of experience in investment management in stock markets. He has worked for over 6 years as Financial Analyst with banks, including Kotak Mahindra Bank, Citibank, and IMGC.

In an interview to Moneycontrol's Kshitij Anand, Sharma expects that the loose global liquidity situation is likely to continue for at least next 2-3 financial years and will trigger further highs for markets in the coming years, he added.

Q) Which sectors are likely to hog the limelight in FY22?

A) Given the Government’s resolve, we believe that privatization could be the story to buy for FY 2022. With Air India, BPCL, Shipping Corporation in advance stages of being sold, and several others in the queue, this time, it seems GOI will be able to actually do it.

Also, noticeable is the privatization/monetization of various assets for e.g. discom operations of UT and other major states (our pick is CESC Ltd.) and Airports.

Other than this, we like Chemical (including API and Pharma) and we also think that despite the run up these shares have seen, there is immense upside still left.

With Anti-China actions and China+1 looking a reality, the Chemical sector is bound to flourish in the near future. We like Valiant Organics Ltd and Caplin Point Laboratories Ltd in this space.
Q) Small & Midcaps came to the limelight in FY21 and do you think the momentum will continue in FY22 as compared to large-caps and why?

A) The rally we have seen in FY 2020-21, could be compared with the rally that started prior to the 2014 general elections. That rally lasted for like 4 years and mid and small caps were real winners.

This time too we think that mid and small-cap will outperform the markets. However, in the euphoria, don’t forget the fundamentals of the company. Because ‘It's only when the tide goes out that you learn who has been swimming naked.

In our opinion, the Large Cap space will grow at a rate more or less representing the economic growth as we see them facing a mild saturation kind of a situation.

However, selected mid and small-cap counters have room to grow disproportionately. We keep looking for companies with lesser debt and growth plans.

Disclaimer: The views and investment tips expressed by experts on Moneycontrol.com are their own and not those of the website or its management. Moneycontrol.com advises users to check with certified experts before taking any investment decisions.